LEADER 02424nam 2200589 a 450 001 9910141381203321 005 20200520144314.0 010 $a1-118-48234-4 010 $a1-118-48249-2 010 $a1-283-70015-8 010 $a1-118-48238-7 035 $a(CKB)2670000000269201 035 $a(EBL)1046781 035 $a(OCoLC)818113410 035 $a(SSID)ssj0000754650 035 $a(PQKBManifestationID)11496231 035 $a(PQKBTitleCode)TC0000754650 035 $a(PQKBWorkID)10726381 035 $a(PQKB)10427657 035 $a(MiAaPQ)EBC1046781 035 $a(Au-PeEL)EBL1046781 035 $a(CaPaEBR)ebr10615075 035 $a(CaONFJC)MIL401265 035 $a(PPN)178273112 035 $a(EXLCZ)992670000000269201 100 $a20120727d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aProtein kinase CK2$b[electronic resource] /$fedited by Lorenzo A. Pinna 210 $aAmes, Iowa $cWiley-Blackwell $cIUBMB$d2013 215 $a1 online resource (482 p.) 225 0$aWiley-IUBMB series on biochemistry and molecular biology 300 $aDescription based upon print version of record. 311 $a0-470-96303-4 320 $aIncludes bibliographical references and index. 327 $apt. 1. Molecular and structural aspects -- pt. 2. Functional aspects -- pt. 3. CK2 and Neoplasia. 330 $a The importance of CK2 in cancer and other diseases has generated a significant amount of literature on the protein, and an international community of CK2 researchers. The International Union of Biochemistry and Molecular Biology (IUMBMB) sponsors periodic international conferences on CK2, making the protein a natural topic for a Wiley-IUBMB publication. Protein Kinase CK2 will deal with structural aspects underlying the constitutive activity of CK2, its specific susceptibility to pharmacological inhibition and its extraordinary pleiotropy. In the second part the fundamental role of CK 410 4$aThe Wiley-IUBMB Series on Biochemistry and Molecular Biology 606 $aProtein kinase CK2 615 0$aProtein kinase CK2. 676 $a612/.015756 701 $aPinna$b Lorenzo A$0949225 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910141381203321 996 $aProtein kinase CK2$92145509 997 $aUNINA